The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy.
Saved in:
| Title: | The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy. |
|---|---|
| Authors: | Chen Y; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China., Chen S; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China., Zhang H; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China., Song B; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.; The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China., Xu Y; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn.; The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42371109 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Chen+S%22">Chen S</searchLink>; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Song+B%22">Song B</searchLink>; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.; The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn.; The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2026 Jun 29. <i>Date of Electronic Publication: </i>2026 Jun 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42371109 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-026-04442-8 Languages: – Code: eng Text: English Titles: – TitleFull: The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Chen S – PersonEntity: Name: NameFull: Zhang H – PersonEntity: Name: NameFull: Song B – PersonEntity: Name: NameFull: Xu Y IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 06 Text: 2026 Jun 29 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0851 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |
